ข่าวประชาสัมพันธ์ Press Releases ข่าวย้อนหลัง หัวข้อข่าว บลอก

วันเสาร์ที่ ๒๓ กุมภาพันธ์ พ.ศ. ๒๕๖๒ ๐๒:๓๕ น.

Food and Healthcare Press Releases

Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Heathcare—๒๑ ก.พ. ๖๒

-- Overall response rate exceeded specified study midpoint target (n=25); company elects to discontinue further patient enrollment as allowed by protocol -- Mallinckrodt plc (NYSE:MNK), a leading global specialty pharmaceutical company, today announced

Takeda, Microsoft and EURORDIS release report with action plan to help rare disease community Heathcare—๒๑ ก.พ. ๖๒

- Global Commission's recommendations focus on three solution pathways that leverage technology to address key elements of the rare disease diagnostic odyssey - Rare diseases remain undiagnosed as patients struggle to navigate complex health systems to

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Heathcare—๑๘ ก.พ. ๖๒

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย Heathcare—๑๘ ก.พ. ๖๒

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Heathcare—๑๘ ก.พ. ๖๒

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(http://www.isabs.net)

Beijing Intellectual Property Court Confirms Judgment Against Wuxi Hisky Medical for Patent Heathcare—๑๕ ก.พ. ๖๒

Echosens, an innovative high-technology company offering the FibroScan family of products dedicated to assessment of chronic liver disease, today announces that the Beijing Intellectual Property Court has confirmed judgment against Wuxi Hisky Medical,

5 Ways to Set Healthy Grocery Shopping Habits in 2019 Heathcare—๑๓ ก.พ. ๖๒

By Susan Bowerman, M.S., RD, CSSD, CSOWM, FAN, Senior Director, Worldwide Nutrition Education and Training Make your daily staples as healthy as you can. Small changes in the foods you eat every day can add up to big rewards. The holidays are over, and

Texas Cardiac Arrhythmia Institute at St. David#s Medical Center first in U.S. to treat patient in Heathcare—๑๓ ก.พ. ๖๒

The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently performed the first procedure in the U.S. using the new HELIOSTAR Multi-electrode Radiofrequency (RF) Balloon Ablation Catheter as part of the STELLAR study. The study

FDA Accepts sBLA and Grants Priority Review for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) Heathcare—๑๒ ก.พ. ๖๒

Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for BAVENCIO(R) (avelumab) in combination with INLYTA(R) (axitinib)*

BioLineRx Announces Closing of $15.4 Million Underwritten Public Offering of its American Heathcare—๘ ก.พ. ๖๒

BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that it has closed its previously announced underwritten public offering of 28,000,000 American Depositary Shares ("ADSs"),

OneTouch(R) Blood Glucose Monitoring System Accuracy Proven in New Long-Term Heathcare—๘ ก.พ. ๖๒

Research demonstrates clinical accuracy of OneTouch Select Plus(R) platform, and demonstrates the value of a continuous and systematic testing program to verify product performance for as long as it has been available to patients New research published

Merck to Expand US Biopharmaceutical RD Facility to Advance Innovative Clinical Heathcare—๗ ก.พ. ๖๒

Merck to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline - Merck investing $70 million in U.S. Research & Development Hub - Expansion of R&D footprint to accelerate science and innovation in Oncology,

BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Heathcare—๖ ก.พ. ๖๒

BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that it has priced an underwritten public offering of 28,000,000 American Depositary Shares ("ADSs"), each representing one

Merck and GSK Announce Global Alliance to Jointly Develop and Commercialize M7824, a Novel Heathcare—๖ ก.พ. ๖๒

- Eight high priority immuno-oncology clinical development studies ongoing or expected to commence in 2019, including studies in non-small cell lung and biliary tract cancers - Merck will receive an upfront payment of EUR300 million and is eligible for

Kaneka invests in a US-based medical device company Heathcare—๕ ก.พ. ๖๒

Kaneka Corporation (Tokyo, Japan, President: Mamoru Kadokura) has entered into an investment and strategic agreement with an undisclosed US-based medical device company ("Company"). According to this agreement, Kaneka has made an investment in 18.5%

Herbalife Nutrition Renews Contract with Brand Ambassador Yo Yossavadee to Continue Promoting Heathcare—๕ ก.พ. ๖๒

Thailand - Herbalife Nutrition, a premier global nutrition company whose purpose is to make the world healthier and happier, recently renewed its contract with famous sports athlete Yossavadee Hassadeevichit (Yo), as Herbalife Nutrition Thailand Brand

Healthcare IT News Asia Pacific Announces Thai Edition Heathcare—๔ ก.พ. ๖๒

Following the official launch of the Asia Pacific regional edition of Healthcare IT News (HITN) in November 2018, HIMSS Asia Pacific today announced the launch of the Thai language edition of HITN. HITN is the industry's authoritative source covering

Doctors Talk: 5 Easy Steps to Start a Healthier, Happier New Year By Dr. Korakod Panich (M.D.), Heathcare—๑ ก.พ. ๖๒

We welcome 2019 with joy, after having celebrated the long holidays having fun, relaxing and recovering from cumulative stress from the past year. However, we must keep in mind that the best New Year gift we can give ourselves is good health. Here are

/C O R R E C T I O N/ - Hoshi Corporation/ Heathcare—๓๑ ม.ค. ๖๒

In the news release, "Hoshi Corporation Starts Accepting Orders for Manufacturing Made-in-Japan Cosmetic Products by Fully Utilizing Bonded Cosmetic Factory" issued on 29-Jan-2019 by Hoshi Corporation, we are advised that the company's name in paragraph

Beckman Coulter#s Automated Microplate System Provides High-Volume Laboratories with Unmatched Heathcare—๓๑ ม.ค. ๖๒

- The new PK7400 leverages Beckman Coulter's more than 30-year customer proven reliability, accuracy and workload capacity Beckman Coulter, a global leader in the clinical diagnostics industry, announced today the launch of its next-generation fully

Santen Hosts Event to Raise Public Awareness of Importance of Continued Glaucoma Treatment Prior to Heathcare—๓๐ ม.ค. ๖๒

As part of its efforts to raise public awareness of glaucoma, Santen Pharmaceutical Co., Ltd. (hereinafter "Santen"), based in Osaka, will sponsor glaucoma awareness-raising activities to be conducted around the world during the World Glaucoma Week, from

Bid Goodbye to Age-Related Cognitive Decline with These 3 Healthy Aging Tips By Dr Gary Small, Heathcare—๒๙ ม.ค. ๖๒

Older adults often discuss the physical and mental changes they experience with aging, but the reality is - none of us are exempt from the effects of aging, especially people living in the Asia Pacific - the fastest aging region in the world. All across

Hoshi Corporation Starts Accepting Orders for Manufacturing Made-in-Japan Cosmetic Products by Heathcare—๒๙ ม.ค. ๖๒

Hoshi Corporation, the Tokyo-based OEM and ODM cosmetic company, has received a license from the Okinawa Regional Customs to operate Japan's first bonded cosmetic factory. The company is strongly geared toward exporting OEM and ODM cosmetic products

Berlinger Confirms Continued Production of Its Anti-doping Products Heathcare—๒๙ ม.ค. ๖๒

Berlinger Special AG will continue to manufacture and supply the containers used in its anti-doping sample control kits from Switzerland, the company's Board of Directors announced today. The BEREG anti-doping kits are the most widely used and proven in